- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants
The study also found lasting benefits of the supplement for bone density up to age 4.
A version of this article was originally published on Dermatology Times by Senior Editor Carrie Nagorka. This version has been lightly edited.
Pregnant women who take cholecalciferol (vitamin D) supplements during pregnancy could significantly decrease the chance of their children having eczema, according to a recent study by researchers at the University of Southampton’s Medical Research Council Lifecourse Epidemiology Centre in England.
The double-blind, randomized placebo-controlled trial examined the relationship between maternal vitamin D supplementation during pregnancy with children suffering from eczema at ages 12, 24, and 48 months. More than 700 pregnant women were either given cholecalciferol 1000 IU/day or a placebo, taken from 14 weeks gestation until delivery. The prevalence of atopic eczema in the offspring was ascertained at ages 12 (n = 635), 24 (n = 610) and 48 (n = 449) months, based on the United Kingdom (UK) Working Party criteria for the definition of atopic dermatitis.
Investigators found that offspring of mothers who received vitaman D 1000 IU daily had a lower chance of atopic eczema at age 12 months (odds ratio [OR], 0.55, 95% CI, 0.32-0.97; P = .04]; this was not statistically significant at ages 24 months (OR, 0.76; 95% CI, 0.47-1.23) or 48 months (OR, 0.75, 95% CI, 0.37-1.52). These are the first data to provide randomized controlled trial evidence of a protective effect of antenatal cholecalciferol supplementation on the risk of infantile atopic eczema.
The investigators also highlighted that more research is needed to determine why the effect was reduced at 24 and 48 months.
This research was part of the Maternal Vitamin D Osteoporosis (MAVIDOS) study in the United Kingdom, which also found that taking the vitamin D supplement during pregnancy had lasting benefits for the child’s bone density at age 4 years.
Lead author Sarah El-Heis, MD, said “Our results show that babies of mothers who received supplements had a lower chance of having atopic eczema at 12 months, which supports recommendations for vitamin D supplements to be routine during pregnancy”.
Reference
El-Heis S, D'Angelo S, Curtis EM, et al. MAVIDOS Trial Group. Maternal antenatal vitamin D supplementation and offspring risk of atopic eczema in the first 4 years of life: evidence from a randomized controlled trial. Br J Dermatol. 2022;187(5):659-666. doi:10.1111/bjd.21721
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
